These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 23340260

  • 1. In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab.
    Chen JL, Wang JY, Tsai YF, Lin YH, Tseng LM, Chang WC, King KL, Chen WS, Chiu JH, Shyr YM.
    Menopause; 2013 Jun; 20(6):646-54. PubMed ID: 23340260
    [Abstract] [Full Text] [Related]

  • 2. In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen.
    Chen JL, Chang CJ, Wang JY, Wen CS, Tseng LM, Chang WC, Noomhorm N, Liu HJ, Chen WS, Chiu JH, Shyr YM.
    Integr Cancer Ther; 2014 May; 13(3):226-39. PubMed ID: 24525674
    [Abstract] [Full Text] [Related]

  • 3. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.
    Anticancer Res; 2006 May; 26(3A):1773-84. PubMed ID: 16827106
    [Abstract] [Full Text] [Related]

  • 4. In vitro and in vivo effects of combination of Trastuzumab (Herceptin) and Tamoxifen in breast cancer.
    Wang CX, Koay DC, Edwards A, Lu Z, Mor G, Ocal IT, Digiovanna MP.
    Breast Cancer Res Treat; 2005 Aug; 92(3):251-63. PubMed ID: 16155796
    [Abstract] [Full Text] [Related]

  • 5. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
    O'Regan RM, Osipo C, Ariazi E, Lee ES, Meeke K, Morris C, Bertucci A, Sarker MA, Grigg R, Jordan VC.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2255-63. PubMed ID: 16609042
    [Abstract] [Full Text] [Related]

  • 6. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Nutr Cancer; 2007 Apr 01; 58(2):162-70. PubMed ID: 17640162
    [Abstract] [Full Text] [Related]

  • 7. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Exp Biol Med (Maywood); 2007 Sep 01; 232(8):1071-80. PubMed ID: 17720953
    [Abstract] [Full Text] [Related]

  • 8. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
    Osipo C, Gajdos C, Cheng D, Jordan VC.
    J Steroid Biochem Mol Biol; 2005 Feb 01; 93(2-5):249-56. PubMed ID: 15860267
    [Abstract] [Full Text] [Related]

  • 9. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
    Du Y, Shi A, Han B, Li S, Wu D, Jia H, Zheng C, Ren L, Fan Z.
    Int J Oncol; 2014 Apr 01; 44(4):1385-93. PubMed ID: 24535190
    [Abstract] [Full Text] [Related]

  • 10. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor.
    Tseng PH, Wang YC, Weng SC, Weng JR, Chen CS, Brueggemeier RW, Shapiro CL, Chen CY, Dunn SE, Pollak M, Chen CS.
    Mol Pharmacol; 2006 Nov 01; 70(5):1534-41. PubMed ID: 16887935
    [Abstract] [Full Text] [Related]

  • 11. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
    Chen J, Hui E, Ip T, Thompson LU.
    Clin Cancer Res; 2004 Nov 15; 10(22):7703-11. PubMed ID: 15570004
    [Abstract] [Full Text] [Related]

  • 12. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May 15; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

  • 13. Trastuzumab therapy for tamoxifen-stimulated endometrial cancer.
    Osipo C, Meeke K, Liu H, Cheng D, Lim S, Weichel A, Jordan VC.
    Cancer Res; 2005 Sep 15; 65(18):8504-13. PubMed ID: 16166331
    [Abstract] [Full Text] [Related]

  • 14. Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
    Osipo C, Meeke K, Cheng D, Weichel A, Bertucci A, Liu H, Jordan VC.
    Int J Oncol; 2007 Feb 15; 30(2):509-20. PubMed ID: 17203234
    [Abstract] [Full Text] [Related]

  • 15. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
    Zavodovskaya M, Campbell MJ, Maddux BA, Shiry L, Allan G, Hodges L, Kushner P, Kerner JA, Youngren JF, Goldfine ID.
    J Cell Biochem; 2008 Feb 01; 103(2):624-35. PubMed ID: 17562544
    [Abstract] [Full Text] [Related]

  • 16. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.
    Brünner N, Bronzert D, Vindeløv LL, Rygaard K, Spang-Thomsen M, Lippman ME.
    Cancer Res; 1989 Mar 15; 49(6):1515-20. PubMed ID: 2924304
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL, Yakes FM, Muthuswamy SK, Bianco R, Simpson JF, Arteaga CL.
    Cancer Res; 2001 Dec 15; 61(24):8887-95. PubMed ID: 11751413
    [Abstract] [Full Text] [Related]

  • 18. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.
    Int J Oncol; 2005 Apr 15; 26(4):1025-31. PubMed ID: 15753998
    [Abstract] [Full Text] [Related]

  • 19. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.
    Ju YH, Doerge DR, Allred KF, Allred CD, Helferich WG.
    Cancer Res; 2002 May 01; 62(9):2474-7. PubMed ID: 11980635
    [Abstract] [Full Text] [Related]

  • 20. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.
    Fan P, Wang J, Santen RJ, Yue W.
    Cancer Res; 2007 Feb 01; 67(3):1352-60. PubMed ID: 17283173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.